Royal Bank of Canada’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $655M | Buy |
|
|||||
|
2025
Q1 | $816M | Sell |
|
|||||
|
2024
Q4 | $813M | Buy |
|
|||||
|
2024
Q3 | $559M | Buy |
|
|||||
|
2024
Q2 | $284M | Sell |
|
|||||
|
2024
Q1 | $429M | Buy |
|
|||||
|
2023
Q4 | $350M | Buy |
|
|||||
|
2023
Q3 | $367M | Sell |
|
|||||
|
2023
Q2 | $415M | Buy |
|
|||||
|
2023
Q1 | $408M | Sell |
|
|||||
|
2022
Q4 | $507M | Buy |
|
|||||
|
2022
Q3 | $423M | Sell |
|
|||||
|
2022
Q2 | $460M | Buy |
|
|||||
|
2022
Q1 | $434M | Sell |
|
|||||
|
2021
Q4 | $470M | Buy |
|
|||||
|
2021
Q3 | $358M | Sell |
|
|||||
|
2021
Q2 | $482M | Buy |
|
|||||
|
2021
Q1 | $403M | Sell |
|
|||||
|
2020
Q4 | $461M | Buy |
|
|||||
|
2020
Q3 | $396M | Buy |
|
|||||
|
2020
Q2 | $342M | Buy |
|
|||||
|
2020
Q1 | $316M | Sell |
|
|||||
|
2019
Q4 | $413M | Buy |
|
|||||
|
2019
Q3 | $311M | Buy |
|
|||||
|
2019
Q2 | $241M | Sell |
|
|||||
|
2019
Q1 | $259M | Sell |
|
|||||
|
2018
Q4 | $330M | Buy |
|
|||||
|
2018
Q3 | $347M | Sell |
|
|||||
|
2018
Q2 | $310M | Buy |
|
|||||
|
2018
Q1 | $353M | Buy |
|
|||||
|
2017
Q4 | $339M | Buy |
|
|||||
|
2017
Q3 | $305M | Buy |
|
|||||
|
2017
Q2 | $261M | Buy |
|
|||||
|
2017
Q1 | $245M | Buy |
|
|||||
|
2016
Q4 | $214M | Buy |
|
|||||
|
2016
Q3 | $182M | Buy |
|
|||||
|
2016
Q2 | $233M | Buy |
|
|||||
|
2016
Q1 | $198M | Sell |
|
|||||
|
2015
Q4 | $215M | Sell |
|
|||||
|
2015
Q3 | $190M | Sell |
|
|||||
|
2015
Q2 | $235M | Buy |
|
|||||
|
2015
Q1 | $219M | Sell |
|
|||||
|
2014
Q4 | $232M | Buy |
|
|||||
|
2014
Q3 | $200M | Buy |
|
|||||
|
2014
Q2 | $154M | Sell |
|
|||||
|
2014
Q1 | $169M | Sell |
|
|||||
|
2013
Q4 | $206M | Buy |
|
|||||
|
2013
Q3 | $141M | Sell |
|
|||||
|
2013
Q2 | $178M | Buy |
|